The Obesity Epidemic: The Lack of Access to Care and Treatment
March 4, 2021 12:00 PM - 1:00 PM
Webinar, click "live-stream" button to view
Add to Calendar
3/4/2021 12:00:00 PM
3/4/2021 1:00:00 PM
The Obesity Epidemic: The Lack of Access to Care and Treatment
Obesity is defined as a disease. Today obesity is one of the major cost drivers to our health care system, linked to diabetes, cardiovascular disease, and cancer. There is ever-increasing medical evidence to support broader access to both evidence-based prevention programs in the community and active medical treatment of obesity. But proper care and treatment of obesity faces challenges in the form of perception, stigma, bias, and roadblocks to accessing treatment, therapies, and care that can help patients. This forum, sponsored by Novo Nordisk, will address these issues and more.
Webinar, click "live-stream" button to view- Angela Fitch, MD, FACP, FOMA
- Associate Director Massachusetts General Hospital Weight Center
- • Associate Director Massachusetts General Hospital Weight Center • Harvard Medical School Faculty • Internal Medicine, Pediatrics and Obesity Medicine • Vice President Obesity Medicine Association
- See All Sessions
- John McDonald
- Corporate Vice President, Head of Global R&D Business Development, Novo Nordisk
- John McDonald joined Novo Nordisk in October 2018. Prior to Novo John held various roles at Biogen Inc., MPM Capital, Genzyme Corporation, Millennium Pharmaceuticals, and Genentech. In his career, John has led or participated in the evaluating, structuring and negotiating of numerous mergers and acquisitions, licenses and strategic alliances, including Biogen’s collaborations with Sangamo BioSciences, AGTC, Mitsubishi Tanabe, UCB, and Portola Pharmaceuticals, Inc. and Biogen’s acquisition of Stromedix, Inc., Millennium's Ex-U.S. collaboration with Ortho Biotech/Johnson & Johnson for VELCADE, the restructuring of Millennium's relationship with Schering-Plough Corp. for INTEGRILIN, and the sale of Millennium's interest in its CAMPATH joint venture, Genzyme’s alliance with BioMarin for ALDURAZYME, and Genentech’s alliances with Xoma Corporation (RAPTIVA), and IDEC Pharmaceuticals (RITUXAN). John holds a J.D. from the University of California, Hastings College of Law, and an M.B.A., Beta Gamma Sigma, and a B.S., Phi Beta Kappa, from the Haas School of Business, University of California, Berkeley.
- See All Sessions
- Zach Stanley
- Executive Director | Bioversity
- Zach is the Executive Director of Bioversity, a newly formed non-profit powered by MassBio that operates workforce training centers, runs training programming, and creates connections among employers, training entities, and students in order to reinvent career pathways for Massachusetts individuals traditionally left out of the life sciences. Formerly, Zach was Chief Corporate Affairs Officer at MassBio where he oversaw the organization’s government affairs, communications, marketing, equity, diversity & inclusion, patient advocacy, and workforce development initiatives. Prior to joining MassBio in 2017, Zach was the Vice President of Public Affairs at Rasky Partners where he specialized in message development, integrated digital advocacy campaigns, government affairs, and coalition building. Zach was formerly a field organizer for the Florida Democratic Party during the 2004 Kerry/Edwards Presidential Campaign and served as the assistant to the Deputy CEO for external affairs of the 2004 Democratic National Convention in Boston. Recently, Zach has served on the American Cancer Society’s Cancer Action Networks’ Reigniting Research Council, as well as on Host Committee for The Children’s Trust’s Celebrating Fatherhood Brunch. Zach earned a bachelor’s degree in Sociology from Boston College. He lives in Westwood with his wife Jessica, their son Reed, and daughter Eleanor.
- See All Sessions
- Melinda J. Watman, RN, BSN, MSN, CNM, MBA
- Chair | Coalition for Action on Obesity (Massachusetts)
- • Chair, Coalition for Action on Obesity (Massachusetts) • Board of Directors, Obesity Action Coalition • President & Founder THE F WORD FAT • Providing science and clinically-based education on obesity • Advocating for access to affordable and comprehensive care
- See All Sessions